Zoetis joins Moon Capital’s portfolio as shares trade near $74.19 after a 51% annual decline despite S&P 500 gains.
Moon Capital Management added Zoetis Inc. (ZTS) to its equity portfolio in Q2 2026, purchasing shares at an average price of $73.20. The animal health company closed at $74.19 on July 22, 2026, down 4.66% over the past month and 51.45% over the past year. Zoetis holds a market capitalization of $31.1 billion.
The S&P 500 rose 9.6% in the first half of 2025, driven by AI-related stocks, while Moon Capital’s portfolio gained 4%. The firm’s technology exposure remains at 10%, well below the S&P 500’s 39%, reflecting caution toward large AI investments. Zoetis, the largest pure-play animal health company, was highlighted as a new position in the firm’s investor update.
Moon Capital did not disclose immediate market reactions to the addition, but the move signals confidence in Zoetis despite its recent underperformance.